Closing Bell: Arch Biopartners Inc down on Wednesday (ARCH)

Today during trading, Arch Biopartners Inc stock opened at $1.57 and closed at $1.49. It traded at a low of $1.43 to a high of $1.57.

Shares dipped -5.10 percent from the previous day's close of $1.57.

Today across North America, the TSX Composite closed 1.25% at 23110.81, the S&P 500 closed -0.50% at 5436.44, the Dow Jones Industrial Average closed 0.50% at 40743.33 and the Nasdaq Composite closed -1.28% at 17147.42.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

Trading volume was 38,477 on 126 total trades, while having an average volume of 24,915 over the last 5-days.

The TSX-V overall saw 3,418 price advancers against 1,773 declines and 138 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have reduced -29.05% in the last 12 months, while they have gained 0.68% since the start of 2024.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $100.25 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..